Prototype CT tools for minimally invasive intracerebral hemorrhage evacuation
Official title: Feasibility of the Utilization of Siemens Prototypes in Minimally Invasive ICH Evacuation Treatment
Run by Icahn School of Medicine at Mount Sinai · NCT07455201 · Data updated 2026-11-12
This project will test two Siemens prototype CT tools—a perfusion feature and an automatic hemorrhage detector—to see if they help doctors planning and performing minimally invasive brain-bleed (intracerebral hemorrhage) evacuation in adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | October 31, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT07455201 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) who are scheduled to undergo minimally invasive hemorrhage evacuation at Mount Sinai West are eligible.
✕Probably not a fit
Patients under 18, or those not undergoing minimally invasive hemorrhage evacuation at Mount Sinai West, are not eligible and unlikely to benefit from these specific prototypes.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project prospectively collects pre-procedural CT scans, intra-procedural DynaCT Sine Spin and DynaCT Multiphase scans taken immediately after evacuation, and immediate post-procedural CT scans to test two Siemens prototypes (a perfusion prototype and an automatic hemorrhage detection prototype). In addition, five retrospectively collected pre- and post-procedural datasets acquired during routine care will be included. Treating clinicians will provide structured feedback on feasibility, usefulness, and potential clinical value during minimally invasive ICH procedures at Mount Sinai West. The aim is to characterize operational performance and identify potential workflow and outcome benefits of these imaging features.
Why it matters
Potential benefit: If successful, these CT prototypes could help surgeons locate and confirm clot removal more quickly and accurately, potentially improving recovery and reducing complications.
How similar studies have gone: Imaging-guided approaches for ICH have shown promise, but the specific Siemens perfusion and automatic-bleed-detection prototypes tested here are relatively new and have limited published clinical data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient ≥ 18 years old * Patient is planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital Exclusion Criteria: * Patient is \< 18 years old * Patient is not planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital
Where it's running
-
Mount Sinai West
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Christopher Kellner — Icahn School of Medicine at Mount Sinai
- Study coordinator: Emily Svendsen
- Email: Emily.Svendsen@mountsinai.org
- Phone: 212-241-3238
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
-
Chinese multicenter group studies spontaneous intracerebral hemorrhage in adults
This study tests how a large group of adults with spontaneous intracerebral hemorrhage (and a healthy control group) progress over time to understand outcomes and determinants of recovery.
-
Rapid Evacuation and Access of Cerebral Hemorrhage Registry: observing minimally invasive surgery outcomes
This registry collection tests how minimally invasive brain-bleed procedures work in real patients with acute spontaneous intracerebral hemorrhage.
-
Single triple-combination blood pressure pill after intracerebral hemorrhage
This trial tests whether a single pill combining amlodipine, valsartan, and hydrochlorothiazide helps adults who recently had an intracerebral hemorrhage control their blood pressure.
-
Vitamin D treatment after intracerebral hemorrhage
This will try giving higher-dose vitamin D to adults within 96 hours of an intracerebral hemorrhage to see if it helps clear the bleed faster and is safe.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.